Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 8:10 pm Sale |
2025-03-31 | 13G | SI-BONE, Inc. SIBN |
OrbiMed Capital LLC | 2,969,500 7.000% |
-280,000 (-8.62%) |
Filing History |
| 2024-11-14 6:27 pm Purchase |
2024-09-30 | 13G | SI-BONE, Inc. SIBN |
OrbiMed Capital LLC | 3,249,500 7.800% |
944,200 (+40.96%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
OrbiMed Capital LLC | 0 0.000% |
-2,583,821 (Position Closed) |
Filing History |
| 2023-02-14 4:14 pm Sale |
2022-12-31 | 13G | Cybin Inc. CYBN |
OrbiMed Capital LLC | 161,929 3.700% |
-135,211 (-45.50%) |
Filing History |
| 2022-02-11 4:44 pm Purchase |
2021-12-31 | 13G | SI-BONE, Inc. SIBN |
OrbiMed Capital LLC | 2,305,300 6.900% |
2,305,300 (New Position) |
Filing History |
| 2022-02-11 4:32 pm Purchase |
2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
OrbiMed Capital LLC | 2,583,821 8.700% |
90,712 (+3.64%) |
Filing History |
| 2022-02-11 4:20 pm Purchase |
2021-12-31 | 13G | Cybin Inc. CYBN |
OrbiMed Capital LLC | 297,139 7.000% |
297,139 (New Position) |
Filing History |
| 2022-02-11 4:15 pm Sale |
2021-12-31 | 13G | APTOSE BIOSCIENCES INC NO APTOF |
OrbiMed Capital LLC | 0 0.000% |
-8,030,000 (Position Closed) |
Filing History |
| 2021-02-12 5:03 pm Purchase |
2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
OrbiMed Capital LLC | 2,493,109 8.360% |
2,493,109 (New Position) |
Filing History |
| 2021-02-12 4:42 pm Purchase |
2020-12-31 | 13G | APTOSE BIOSCIENCES INC NO APTOF |
OrbiMed Capital LLC | 8,030,000 9.040% |
8,030,000 (New Position) |
Filing History |